Omixon and TBG form Partnership for Asia-Pacific

Omixon and TBG Biotechnology Corp. (TBG), headquartered in Taiwan announce an Exclusive Distribution and Support Partnership for the Asia-Pacific region, including China, Hong Kong, Taiwan and Australia. TBG will be the exclusive distributor of Omixon’s world leading Holotype HLA product for HLA typing by NGS. “With a common goal of driving adoption of NGS...

 

Read more

PLOS ONE: Application of High-Throughput Next-Generation Sequencing for HLA Typing on Buccal Extracted DNA: Results from over 10,000 Donor Recruitment Samples

Authors: Yuxin Yin, James H. Lan, David Nguyen, Nicole Valenzuela, Ping Takemura, Yung-Tsi Bolon, Brianna Springer, Katsuyuki Saito, Ying Zheng, Tim Hague, Agnes Pasztor, Gyorgy Horvath, Krisztina Rigo, Elaine F. Reed, Qiuheng Zhang Abstract: Background Unambiguous HLA typing is important in hematopoietic stem cell transplantation (HSCT), HLA disease association studies, and solid organ transplantation. However, current molecular typing methods only interrogate...

 

Read more

NGS Accreditation with ASHI Standards at the ASHI Annual Meeting 2016

Omixon announce today that Holotype HLA™ and other Omixon products will be featured in four oral presentations and five poster presentations produced by customers or collaborators at the annual meeting of the American Society for Histocompatibility and Immunogenetics (ASHI) in St Louis, MO. Additionally, Omixon’s Lunch Symposium on Thursday will...

 

Read more